RESEARCH-USE BIOSIMILAR ANTIBODY
Margetuximab
Monoclonal antibody · IgG1
Margetuximab (MGAH22) is a chimeric anti-HER2 monoclonal antibody optimized Fc domain, with an EC50 value of 39.33 ng/mL. Margetuximab can be used for researching metastatic HER2-positive breast cancer.
TARGETERBB2
YMonoclonal antibody
CATALOGSC-BS-389
CATALOG NUMBERSC-BS-389
MOLECULAR WEIGHTApprox. 146.1 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Margetuximab (MGAH22) is a chimeric anti-HER2 monoclonal antibody optimized Fc domain, with an EC50 value of 39.33 ng/mL. Margetuximab can be used for researching metastatic HER2-positive breast cancer.
Margetuximab is a recombinant research-use antibody directed against ERBB2.